» Articles » PMID: 3484727

C1 Activation, with C1q in Excess of Functional C1 in Synovial Fluid from Patients with Rheumatoid Arthritis

Overview
Publisher Karger
Date 1986 Jan 1
PMID 3484727
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Free Clq, in functionally active form was present in increased amounts in the synovial fluid of patients with rheumatoid arthritis. The presence of free Clq was associated with low concentrations of hemolytic C1, low C4 and raised amounts of C3dg/d fragments in the synovial fluid. The findings suggested intra-articular C1 activation with dissociation of C1 into free C1q and complexes containing C1r, C1s, and C1 inactivator. However, the immunochemical properties of synovial fluid C1r-C1s-C1 inactivator complexes appeared to differ from those of the complexes formed in serum, which hampered quantification with the assay used. Control patients with osteoarthritis or spondylarthritic syndromes did not show evidence of intra-articular complement activation, even though 1 patient with Reiter's disease had unexplained low concentrations of synovial fluid C4 and C3. The concentrations of circulating complement components were largely normal in the patients. Slightly increased concentrations of free C1q and C1r-C1s-C1 inactivator complexes in serum and C3dg/d fragments in EDTA plasma were observed, particularly in the patients with rheumatoid arthritis.

Citing Articles

Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis.

Perez-Garcia S, Calamia V, Hermida-Gomez T, Gutierrez-Canas I, Carrion M, Villanueva-Romero R Int J Mol Sci. 2021; 22(12).

PMID: 34208590 PMC: 8235106. DOI: 10.3390/ijms22126441.


Complement as a Therapeutic Target in Systemic Autoimmune Diseases.

Galindo-Izquierdo M, Pablos Alvarez J Cells. 2021; 10(1).

PMID: 33451011 PMC: 7828564. DOI: 10.3390/cells10010148.


Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.

Tan E, Smolen J J Exp Med. 2016; 213(10):1937-50.

PMID: 27621417 PMC: 5030811. DOI: 10.1084/jem.20160792.


Complement in the immunopathogenesis of rheumatic disease.

Sturfelt G, Truedsson L Nat Rev Rheumatol. 2012; 8(8):458-68.

PMID: 22664835 DOI: 10.1038/nrrheum.2012.75.


Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.

Happonen K, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom A Arthritis Rheum. 2010; 62(12):3574-83.

PMID: 20737467 PMC: 4576017. DOI: 10.1002/art.27720.